Should I get a gut microbiome test to see if fiber will help my fatty liver?

While commercial microbiome tests are available in the US, the predictive model developed in this Chinese study has not yet been validated for clinical use in American patients or approved by the FDA. At this time, standard microbiome testing cannot reliably guide MASLD treatment decisions. However, this research is a strong step toward making such testing clinically meaningful. Ask your gastroenterologist or endocrinologist about emerging microbiome-based diagnostics and whether any relevant clinical trials are available near you.

How does MASLD relate to type 2 diabetes?

MASLD and type 2 diabetes are closely linked — approximately 50–70% of people with type 2 diabetes also have some degree of fatty liver disease. Insulin resistance, a hallmark of type 2 diabetes, promotes fat accumulation in the liver. Managing blood sugar levels (the American Diabetes Association recommends keeping fasting glucose below 100 mg/dL, or 5.6 mmol/L) can also help reduce liver fat. Treatments that benefit one condition often improve the other, which is why diabetes researchers are closely watching MASLD therapies like resistant starch.

China Study: Gut Bacteria Control Fiber's Fatty Liver Benefits

Key takeaways

✓Identified Prevotella bacteria as the key reason resistant starch fails in 30% of MASLD patients, explaining a long-standing clinical mystery
✓Isolated a specific probiotic strain (B. pseudocatenulatum RRP01) that can restore fiber effectiveness, pointing toward targeted probiotic therapies
✓Developed a predictive model (AUC 0.74–0.87) combining microbiome and clinical data to identify in advance who will respond to resistant starch treatment

Quick specs

Country	China
Journal	Cell metabolism
Year	2025
Authors	Long, Wang, Lu
PMID	41270737

A Study from China Reveals Why Fiber Works for Some Fatty Liver Patients — But Not Others

A study from China, published in the prestigious journal Cell Metabolism (2025), has uncovered a striking reason why a high-fiber dietary supplement helps some people with fatty liver disease dramatically — while doing almost nothing for others. The answer lies deep in your gut: the specific bacteria living in your digestive system appear to determine whether resistant starch, a type of prebiotic fiber, can effectively treat metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD).

What Is MASLD — and Why Does It Matter?

MASLD is one of the fastest-growing liver conditions in the United States, affecting an estimated 80–100 million Americans. It occurs when excess fat builds up in the liver, often linked to obesity, type 2 diabetes, and insulin resistance. There is currently no FDA-approved drug specifically for early-stage MASLD, making dietary interventions like resistant starch particularly important to study.

What the Chinese Researchers Did

Scientists at Shanghai's State Key Laboratory of Metabolic Dysregulation, a leading diabetes and metabolic disease research center, conducted a randomized, placebo-controlled trial giving participants resistant starch (RS) — a fiber found in foods like green bananas, cooked-and-cooled rice, and legumes. While many participants showed meaningful liver improvement, roughly 30% of participants saw limited benefit. This finding was confirmed in a separate multi-center trial.

Using advanced multi-omics analysis (studying genes, proteins, and metabolites simultaneously) and fecal microbiota transplants in animal models, the team identified a clear culprit: a gut bacterium called Prevotella. In patients with high levels of Prevotella, this bacterium appeared to block the beneficial bacteria responsible for breaking down resistant starch — essentially stopping the fiber from doing its job.

On the positive side, researchers isolated a specific beneficial strain called Bifidobacterium pseudocatenulatum RRP01 from their patient cohort. This strain was able to restore resistant starch breakdown and overcome the Prevotella blockage, reopening the door to fiber's liver benefits.

The team also developed a predictive model combining gut microbiome data and standard clinical measurements, achieving an impressive accuracy score (AUC) of 0.74–0.87 — meaning it could reliably predict in advance who would respond to resistant starch therapy.

Why This Matters for US Patients

For the estimated 1 in 4 American adults living with MASLD, this research offers genuinely practical hope. Here is what the findings mean for you:

Your gut bacteria are not a side issue — they are central. Before recommending high-fiber diets or prebiotic supplements for liver disease, your doctor may one day test your microbiome to see if your gut is actually capable of using that fiber effectively.
"Eat more fiber" is not one-size-fits-all. US dietary guidelines currently recommend 25–38 grams of fiber per day for adults, but this research suggests fiber's benefits vary dramatically based on your personal gut ecosystem.
Precision probiotics may be on the horizon. The identification of B. pseudocatenulatum RRP01 as a corrective strain opens the door to targeted probiotic treatments tailored to your specific microbiome profile — a concept gaining traction in US precision medicine research.
A simple predictive test could save time and money. Rather than trying dietary interventions for months without knowing if they will work, a microbiome-based screening test could help American clinicians personalize treatment from day one.

While US and Chinese patients differ in average diet and gut microbiome composition, MASLD is a globally shared epidemic driven by similar metabolic risk factors. The biological mechanisms uncovered here — fiber degradation pathways, bacterial competition, and liver fat metabolism — are universal.

Original Study

Long, Wang, Lu et al. "Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD." Cell Metabolism, 2025. PMID: 41270737. DOI: 10.1016/j.cmet.2025.10.017

References & Sources

Frequently asked questions

Resistant starch is a type of dietary fiber that passes through your small intestine undigested and feeds beneficial gut bacteria in your colon. Good food sources include green (unripe) bananas, cooked-and-cooled potatoes or rice, legumes like lentils and chickpeas, and rolled oats. However, this study suggests that whether resistant starch benefits your liver depends heavily on which bacteria are already living in your gut — so talk to your doctor or dietitian before making major dietary changes specifically to treat fatty liver disease.

Editorial note

This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 12, 2026 by the MDS Diabetes editorial team.

What to do next

📚

China Study: Gut Bacteria Determine If Fiber Treats Fatty Liver